News
Public awareness about the link between human papillomavirus, or HPV, and cancer is low. A doctor explains why its lifesaving ...
14h
ScienceAlert on MSNNew Vaccine For Two Deadly Cancers Shows Promise in Clinical Trial
A new 'off-the-shelf' vaccine with the catchy name ELI-002 2P offers fresh hope for individuals affected by these deadly ...
1d
Medpage Today on MSNNovel Vaccine Shows Promise in Pancreatic Cancer
An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...
A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
1d
Clinical Trials Arena on MSNElicio’s peptide cancer vaccine shows survival benefit in Phase I trial
Elicio's mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key ...
IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's ...
Cancer rates in 2025 are predicted to exceed the previous year's statistics, with one-in-three men and women both at risk of contracting the disease.
A one-size-fits-all vaccine has shown promising results in keeping hard-to-treat pancreatic cancers from coming back. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results